OrbiMed Capital GP VII LLC, 10% Owner at Passage BIO, Inc. (PASG), sold 149,054 shares at $0.38 ($50K) on 2025-04-15, disclosed to the SEC on 2025-04-17.
Open-market sale of $50k PASG by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.38 | 10,326 | $4K | 7.9% |
| 2 | $0.33 | 61,638 | $20K | 40.9% |
| 3 | $0.33 | 77,090 | $25K | 51.2% |
| Total | $0.33 avg | 149,054 | $50K | 100% |
| Filing → |
| PASG | SELL | 2024-12-06 | $77K | — | Filing → |
| PASG | SELL | 2024-09-18 | $147K | — | Filing → |
| ELVN | SELL | 2024-05-20 | $22.9M | — | Filing → |